In this episode, The Price and Policy Podcast looks at U.S. inflation easing to 2.4% headline and 2.5% core, and AbbVie’s $380 million Illinois expansion as a tariff‑driven bet on domestic drug manufacturing.
The Price & Policy Podcast
Business
In this episode, The Price and Policy Podcast looks at U.S. inflation easing to 2.4% headline and 2.5% core, and AbbVie’s $380 million Illinois expansion as a tariff‑driven bet on domestic drug manufacturing.
